Osteoprotective medication in the era of novel agents: a European perspective on values, risks and future solutions

• Monika Engelhardt,
• Georg W. Herget,
• Giulia Graziani,
• Gabriele Ihorst,
• Heike Reinhardt,
• Stefanie Ajayi,
• Stefan Knop,
• Ralph Wasch

Affiliations

Monika Engelhardt

Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, University of Freiburg, Germany

Georg W. Herget

Department of Orthopedics and Trauma Surgery, Medical Center, University of Freiburg, Germany

Giulia Graziani

Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, University of Freiburg, Germany

Gabriele Ihorst

Clinical Trials Unit, Medical Center, University of Freiburg, Germany

Heike Reinhardt

Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, University of Freiburg, Germany

Stefanie Ajayi

Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, University of Freiburg, Germany

Stefan Knop

Hematology, Oncology, Gastroenterology, University of Würzburg, Germany

Ralph Wasch

Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, University of Freiburg, Germany